Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
Condition(s):Biliary Tract Cancer; Gallbladder AdenocarcinomaLast Updated:February 7, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Biliary Tract Cancer; Gallbladder AdenocarcinomaLast Updated:February 7, 2017Completed
Condition(s):Cancer of the Bile Duct; Gallbladder CancerLast Updated:August 1, 2017Withdrawn
Condition(s):Gall Bladder CancersLast Updated:July 6, 2022Recruiting
Condition(s):Cholangiocarcinoma; Gallbladder CancerLast Updated:August 13, 2013Completed
Condition(s):Gallbladder Cancer; Nutritional and Metabolic DiseasesLast Updated:March 12, 2021Completed
Condition(s):Gallbladder CancerLast Updated:September 29, 2022Completed
Condition(s):Cholangiocarcinoma of the Extrahepatic Bile Duct; Gallbladder CancerLast Updated:May 7, 2018Unknown status
Condition(s):Potentially Resectable Locally Advanced Intrahepatic Cholangiocarcinoma and Gallbladder CancerLast Updated:November 17, 2022Recruiting
Condition(s):Proteinosis; Gallbladder CarcinomaLast Updated:July 10, 2018Unknown status
Condition(s):Cholangiocarcinoma of the Extrahepatic Bile Duct; Gallbladder CancerLast Updated:December 7, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.